Genetic influences on lipid metabolism trait variability within the stanislas cohort

Journal of Lipid Research

Volumn 42, Issue 11, 2001, Pages 1879-1890

  Pallaud, C ^a   Gueguen, R ^a   Sass, C ^a   Grow, M ^a   Cheng, S ^a   Siest, G ^a   Visvikis, S ^a  

^a INSERM   (France)

Author keywords

Candidate genes; Healthy population; Lipid variability; Polymorphism

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL ESTER TRANSFER PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HOMOCYSTEINE; LIPOPROTEIN LIPASE;

ADULT; AGE; ARTICLE; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; ORAL CONTRACEPTION; PRIORITY JOURNAL; SEX; SMOKING; THROMBOCYTE AGGREGATION;

ADULT; AGING; ALLELES; APOLIPOPROTEIN A-I; APOLIPOPROTEIN C-III; APOLIPOPROTEINS B; APOLIPOPROTEINS C; APOLIPOPROTEINS E; CHOLESTEROL, LDL; CODON; COHORT STUDIES; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEX CHARACTERISTICS; SMOKING; VARIATION (GENETICS);

EID: 0035200547     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study
2. Prevalence of coronary, heart disease in the Framingham Offspring Study: Role of lipoprotein cholesterols
3. Genes, variation of cholesterol and fat intake and serum lipids
4. Lipid and apolipoprotein predictors of atherosclerosis in youth: Apolipoprotein concentrations do not materially improve prediction of arterial lesions in PDAY subjects
5. Epidemiology of coronary heart disease: The Framingham study
6. Abnormal blood lipids: Is it environment or is it genes?
7. Genetic basis of familial dyslipidemia and hypertension: 15-Year results from Utah
8. Association between blood pressure and serum lipids in a population. The Tromso Study
9. Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation
10. Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis
11. The D allele of the angiotensin-converting enzyme gene contributes towards blood LDL-C levels and the presence of hypertension
12. Levels of soluble cell adhesion molecules in patients with dyslipidemia
13. Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia
14. Inhibition of endothelial cell adhesion molecule expression by high density lipoproteins
15. Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages
16. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine and other risk factors for vascular disease
17. Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population
18. Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients
19. C677T (thennolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): Its frequency and impact on plasma homocysteine concentration in different European populations
20. Purification and identification of the lipoprotein-binding proteins from human blood platelet membrane
21. Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: The Cardiovascular Health Study
22. The relationship between fibrinogen and other coronary heart disease risk factors in a Chinese population
23. The relationship between smoking and triglyceride-rich lipoproteins is modulated by genetic variation in the glycoprotein IIIa gene
24. European Atherosclerosis Research Study: Genotype at the fibrinogen locus (G-455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction
25. A multilocus genotyping assay for candidate markers of cardiovascular disease risk
26. A multilocus genotyping assay for cardiovascular disease
27. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses
28. Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins
29. DNA polymorphisms of the apolipoprotein B and A-I/C-III genes are associated with variations of serum low density lipoprotein cholesterol level in childhood
30. Genetic association of five apolipoprotein polymorphisms with serum lipoprotein-lipid levels in African blacks
31. Candidate-gene studies of the atherogenic lipoprotein phenotype: A sib-pair linkage analysis of DZ women twins
32. Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: The Stanislav cohort
33. A simple salting out procedure for extracting Dna from human nucleated cells
34. Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia
35. Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: Interaction between genotype, gender, and smoking status
36. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo
37. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway
38. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation
39. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. II. Regression relationships with concomitants
40. The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado
41. Evidence that the apolipoprotein E-genotype effects on lipid levels can change with age in males: A longitudinal analysis
42. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study
43. Apolipoprotein B polymorphism and altered apolipoprotein B and low density lipoprotein cholesterol concentrations in Finnish children
44. Physiological significance of apolipoprotein mutants
45. Structure of apolipoprotein B-100 of human low density lipoproteins
46. High serum concentrations of soluble E-selectin in patients with impaired glucose tolerance with hyperinsulinemia
47. DNA polymorphisms in adhesion molecule genes - A new risk factor for early atherosclerosis
48. High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2
49. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1
50. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Mn. III. Correlations and covariances
51. Sources of variation in plasma lipid and lipoprotein traits in a sample selected for health
52. Patterns of association between genetic variability in apolipoprotein (apo) B, apo AI-CIII-AIV, and cholesterol ester transfer protein gene regions and quantitative variation in lipid and lipoprotein traits: Influence of gender and exogenous hormones
53. Multiple genetic determinants of variation of plasma lipoproteins in Alberta Hutterites
54. Genetic analysis of sex and generation differences in plasma lipid, lipoprotein, and apolipoprotein levels in adolescent twins and their parents
55. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians
56. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia
57. Plasma cholesteryl ester transfer protein
58. Interaction of the cholesteryl ester transfer protein I405V polymorphism with alcohol consumption in smoking and non-smoking healthy men, and the effect on plasma HDL cholesterol and apoA-I concentration
59. Paraoxonase as a risk marker for cardiovascular disease: Facts and hypotheses
60. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis
61. The effect of the angiotensinogen M235T and the angiotensin-converting enzyme I/D polymorphisms on arterial hypertension and other cardiovascular risk factors